Mark Neumann - 03 Feb 2026 Form 4 Insider Report for Veradermics, Inc (MANE)

Role: Chief Commercial Officer, Strategy Officer
Signature: /s/ Michael Greco, Attorney-in-Fact
Issuer symbol: MANE
Transactions as of: 03 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 05 Feb 2026, 19:02:00 UTC
Previous filing: 02 Apr 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Neumann Mark	Chief Commercial Officer, Strategy Officer	C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN	/s/ Michael Greco, Attorney-in-Fact	05 Feb 2026	0001756211

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MANE	Stock Option (Right to Buy)	Award	$0	+102,885		$0.000000	102,885	03 Feb 2026	Common Stock	102,885	$17.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests as to 25% of the underlying shares of the Issuer's common stock, par value $0.00001 per share, on February 3, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service.